小分子抑制剂向m6A调节器.
Guotai Feng1, Yongya Wu1, Yuan Hu1,2
1Department of Biotherapy, Cancer Center and State Key Laboratory of Biotherapy, Innovation Center of Nursing Research, Nursing Key Laboratory of Sichuan Province, National Clinical Research Center for Geriatrics, West China Hospital, and West China Second Hospital, Sichuan University /West China School of Nursing, Sichuan University, Chengdu, 610041, China.
Journal of hematology & oncology
|May 6, 2024
概括
甲基氨酸 (m6A) 修饰调节关键的细胞过程和癌症的发展. 针对m6A调节者的小分子通过干预RNA修饰和瘤细胞存活提供了新的抗瘤策略.
科学领域:
- 表观遗传学 在表观遗传学中,表观遗传学是指表观遗传学.
- RNA生物学的RNA生物学
- 癌症研究 癌症研究
背景情况:
- 甲基氨酸 (m6A) 是一种普遍存在的RNA修饰,影响生长,发育和DNA损伤反应.
- 异常6 癌症中的表达促进了瘤的进展,影响了扩散,转移,耐药性,免疫力和预后.
- m6A在癌症中的作用导致了针对抗瘤疗法的m6A调节体的小分子的开发.
研究的目的:
- 综合审查m6A调节器,它们的功能,以及与癌症特征的相互作用.
- 提供针对癌症治疗的m6A调节体的小分子概述,包括它们的发展,作用机制,药理学和结构-活性关系.
- 为未来的药物设计和优化提供洞察力,以准癌症治疗的m6A.
主要方法:
- 文献综述和对m6A调节剂和小分子抑制剂现有研究的综合.
- 分析m6A调节器在癌症扩散,转移,耐药性和免疫反应中的功能.
- 收集和讨论关于小分子的发展,药理学和结构-活性关系的数据,这些数据针对m6A调节器.
主要成果:
- m6A调节剂在各种癌症中发挥关键作用,影响瘤细胞行为和患者的结果.
- 针对m6A调节者的小分子显示出精确干预RNA修饰的潜力.
- 这些小分子破坏瘤细胞生存机制,提供了新的抗癌治疗途径.
结论:
- m6 修改是癌症生物学中的一个重要因素,提供治疗机会.
- 针对m6A调节者的小分子是新型癌症治疗的有希望的药物.
- 对小分子开发的进一步研究,以 m6A 调节剂为目标,有必要进行进一步的研究,以优化药物设计和未来的临床应用.
相关概念视频
01:29Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship
554
Indirect-acting cholinergic agonists are agents that interact with the acetylcholinesterase enzyme in the synaptic cleft, preventing the breakdown of acetylcholine into choline and acetate. Consequently, the concentration of acetylcholine in the synaptic cleft increases. These agonists can be classified into reversible and irreversible inhibitors based on their duration of action.
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
554
01:26Targets for Drug Action: Overview
6.2K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
6.2K
01:18Indirect-Acting Cholinergic Agonists: Mechanism of Action
1.8K
Indirect-acting cholinergic agonists work by interacting with an enzyme called acetylcholinesterase (AChE) in the synaptic cleft. They can be reversible or irreversible inhibitors and have different effects on the enzyme.
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
1.8K
01:56Riboswitches
8.1K
Riboswitches are non-coding mRNA domains that regulate the transcription and translation of downstream genes without the help of proteins. Riboswitches bind directly to a metabolite and can form unique stem-loop or hairpin structures in response to the amount of the metabolite present. They have two distinct regions – a metabolite-binding aptamer and an expression platform.
The aptamer has high specificity for a particular metabolite which allows riboswitches to specifically regulate...
The aptamer has high specificity for a particular metabolite which allows riboswitches to specifically regulate...
8.1K
01:30Enzyme Inhibition
78.3K
Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
78.3K
01:22MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K